drugset / Trial / NCT01023178
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.
Timeline
- Start
- 2007-02
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 17-beta estradiol | Unknown | 0.05 mg | Oral |
| Comparator | 17-beta estradiol | Unknown | 1 mg | Oral |
| Comparator | Progesterone | Other / unclassified | — | — |
| Comparator | conjugated estrogens | Other / unclassified | 0.625 mg | Oral |